Neion Bio

Neion Bio is a biotechnology company that develops life-saving products derived from nature molecular factories, utilizing advanced genetic engineering to harness the power of biology for creating innovative therapeutic solutions. The company technology leverages principles of evolutionary biology and genetic engineering to develop transformative products, focusing on natural molecular factories as a source of novel compounds with therapeutic potential. Neion Bio approach enables the discovery and development of new treatments by engineering biological systems to produce molecules that may be difficult or impossible to synthesize through traditional chemical methods. The company platform is designed to create innovative solutions for unmet medical needs by tapping into the diversity of natural biosynthetic pathways. Founded in 2024 and headquartered in New York City, Neion Bio has raised $23 million in Series A funding from investors including Caffeinated, Basis Set Ventures, Haystack, Digitalis Ventures, Ensemble, and Trust Ventures.